PIK3CA and melanoma: Various mechanisms of PI3K/AKT hyperactivation have been described in the melanoma literature, including RTK amplification, activating mutations in and increased gene expression of PI3KCA, as well as genomic amplification and activating mutations in AKT [76,83,84,85].